Skip to content

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06665503
Acronym
AAD
Enrollment
165
Registered
2024-10-30
Start date
2020-09-01
Completion date
2021-05-01
Last updated
2024-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic-associated Diarrhea, Diarrhea

Keywords

antibiotic-associated diarrhea, children zinc, probiotics, zinc, probiotics

Brief summary

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Detailed description

The participants will be children aged 3 months to 3 years.The zinc group received oral zinc supplementation; 2.5 ml every 12 hours for children aged \<1 year and 5 ml every 12 hours for older children; the probiotics group received oral probiotics; 1 probiotic sachet; and the control group received nothing.

Interventions

DIETARY_SUPPLEMENTZinc Supplement, probiotic

received oral zinc supplementation; 2.5 ml every 12 hours for children aged \<1 year and 5 ml every 12 hours for older children; the probiotics group received oral probiotics; 1 probiotic sachet

Sponsors

Hormozgan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

Randomly assigned to three groups of equal size, exclusively receiving the standard antibiotic regimen or the zinc and probiotics groups

Eligibility

Sex/Gender
ALL
Age
3 Months to 3 Years
Healthy volunteers
Yes

Inclusion criteria

1. children aged 3 months to 3 years 2. prescribed antibiotics for various medical conditions

Exclusion criteria

1. Diarrhea, Dysentery 2. Underlying chronic disease

Design outcomes

Primary

MeasureTime frameDescription
Rate of Antibiotic-Associated Diarrhea6 monthPassing loose, watery stools three or more times a day after taking antibiotic by questionnaire.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026